In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 12, 2009, Pages 5069-5073

  Mwai, Leah ^a,b   Kiara, Steven M ^a   Abdirahman, Abdi ^a   Pole, Lewa ^a   Rippert, Anja ^c   Diriye, Abdi ^a   Bull, Pete ^a   Marsh, Kevin ^a,b   Borrmann, Steffen ^a,c   Nzila, Alexis ^a,b  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; BENFLUMETOL; CHLOROQUINE; DIHYDROARTEMISININ; PIPERAQUINE;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CHEMOSENSITIVITY; CODON; DNA POLYMORPHISM; DRUG ACTIVITY; GENE MUTATION; GENE NUMBER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; IC 50; IN VITRO STUDY; MICROBIAL GROWTH; NONHUMAN; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; ANTIMALARIALS; ARTEMISININS; ETHANOLAMINES; FLUORENES; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; QUINOLINES;

EID: 71249142664     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00638-09     Document Type: Article

References (42)

1. Anderson, T. J., S. Nair, H. Qin, S. Singlam, A. Brockman, L. Paiphun, and F. Nosten. 2005. Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance? Antimicrob. Agents Chemother. 49:2180-2188.
2. Barends, M., A. Jaidee, N. Khaohirun, P. Singhasivanon, and F. Nosten. 2007. In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border. Malar. J. 6:81.
3. Basco, L. K., and P. Ringwald. 2003. In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon. Antimicrob. Agents Chemother. 47:1391-1394.
4. Basco, L. K., and P. Ringwald. 2007. Molecular epidemiology of malaria in Cameroon. XXIV. Trends of in vitro antimalarial drug responses in Yaounde, Cameroon. Am. J. Trop. Med. Hyg. 76:20-26.
5. Chinbuah, A. M., J. O. Gyapong, F. Pagnoni, E. K. Wellington, and M. Gyapong. 2006. Feasibility and acceptability of the use of artemether- lumefantrine in the home management of uncomplicated malaria in children 6-59 months old in Ghana. Trop. Med. Int. Health 11:1003-1016.
6. Deloron, P., J. Le Bras, J. A. Ramanamirija, and P. Coulanges. 1985. Plasmodium falciparum in Madagascar: in vivo and in vitro sensitivity to seven drugs. Ann. Trop. Med. Parasitol. 79:357-365.
7. Dokomajilar, C., S. L. Nsobya, B. Greenhouse, P. J. Rosenthal, and G. Dorsey. 2006. Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob. Agents Chemother. 50:1893-1895.
8. Dondorp, A. M., F. Nosten, P. Yi, D. Das, A. P. Phyo, J. Tarning, K. M. Lwin, F. Ariey, W. Hanpithakpong, S. J. Lee, P. Ringwald, K. Silamut, M. Imwong, K. Chotivanich, P. Lim, T. Herdman, S. S. An, S. Yeung, P. Singhasivanon, N. P. Day, N. Lindegardh, D. Socheat, and N. J. White. 2009. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361:455-467.
9. Duraisingh, M. T., P. Jones, I. Sambou, L. von Seidlein, M. Pinder, and D. C. Warhurst. 2000. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials me- floquine and artemisinin. Mol. Biochem. Parasitol. 108:13-23.
10. Duraisingh, M. T., C. Roper, D. Walliker, and D. C. Warhurst. 2000. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol. Microbiol. 36:955-961.
11. Falade, C. O., A. O. Ogundele, B. O. Yusuf, O. G. Ademowo, and S. M. Ladipo. 2008. High efficacy of two artemisinin-based combinations (artemether- lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria. Trop. Med. Int. Health 13:635-643.
12. Falade, C. O., O. O. Ogunkunle, H. O. Dada-Adegbola, A. G. Falade, P. Ibarra de Palacios, P. Hunt, M. Virtanen, A. M. Oduola, and L. A. Salako. 2008. Evaluation of the efficacy and safety of artemether-lumefantrine in the treatment of acute uncomplicated Plasmodium falciparum malaria in Nigerian infants and children. Malar. J. 7:246.
13. Happi, C. T., G. O. Gbotosho, O. A. Folarin, A. Sowunmi, T. Hudson, M. O'Neil, W. Milhous, D. F. Wirth, and A. M. Oduola. 2009. Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes by artemether-lumefantrine in Nigerian children with uncomplicated falciparum malaria. Antimicrob. Agents Chemother. 53:888-895.
14. Holmgren, G., A. Bjorkman, and J. P. Gil. 2006. Amodiaquine resistance is not related to rare findings of pfmdr1 gene amplifications in Kenya. Trop. Med. Int. Health 11:1808-1812.
15. Humphreys, G. S., I. Merinopoulos, J. Ahmed, C. J. Whitty, T. K. Mutabingwa, C. J. Sutherland, and R. L. Hallett. 2007. Amodiaquine and artemether- lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Antimicrob. Agents Chemother. 51:991-997.
16. Kaddouri, H., A. Djimde, S. Dama, A. Kodio, M. Tekete, V. Hubert, A. Kone, H. Maiga, O. Yattara, B. Fofana, B. Sidibe, C. P. Sangare, O. Doumbo, and J. Le Bras. 2008. Baseline in vitro efficacy of ACT component drugs on Plasmodium falciparum clinical isolates from Mali. Int. J. Parasitol. 38:791-798.
17. Karunajeewa, H. A., I. Mueller, M. Senn, E. Lin, I. Law, P. S. Gomorrai, O. Oa, S. Griffin, K. Kotab, P. Suano, N. Tarongka, A. Ura, D. Lautu, M. Page-Sharp, R. Wong, S. Salman, P. Siba, K. F. Ilett, and T. M. Davis. 2008. A trial of combination antimalarial therapies in children from Papua New Guinea. N. Engl. J. Med. 359:2545-2557.
18. Kobbe, R., P. Klein, S. Adjei, S. Amemasor, W. N. Thompson, H. Heidemann, M. V. Nielsen, J. Vohwinkel, B. Hogan, B. Kreuels, M. Buhrlen, W. Loag, D. Ansong, and J. May. 2008. A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children. Malar. J. 7:261.
19. Kokwaro, G., L. Mwai, and A. Nzila. 2007. Artemether/lumefantrine in the treatment of uncomplicated falciparum malaria. Expert Opin. Pharmacother. 8:75-94.
20. Lim, P., A. P. Alker, N. Khim, N. K. Shah, S. Incardona, S. Doung, P. Yi, D. M. Bouth, C. Bouchier, O. M. Puijalon, S. R. Meshnick, C. Wongsrichanalai, T. Fandeur, J. Le Bras, P. Ringwald, and F. Ariey. 2009. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar. J. 8:11.
21. Mayxay, M., M. Barends, A. Brockman, A. Jaidee, S. Nair, D. Sudimack, T. Pongvongsa, S. Phompida, R. Phetsouvanh, T. Anderson, N. J. White, and P. N. Newton. 2007. In vitro antimalarial drug susceptibility and pfcrt mutation among fresh Plasmodium falciparum isolates from the Lao PDR (Laos). Am. J. Trop. Med. Hyg. 76:245-250.
22. Muangnoicharoen, S., D. J. Johnson, S. Looareesuwan, S. Krudsood, and S. A. Ward. 2009. Role of known molecular markers of resistance in the antimalarial potency of piperaquine and dihydroartemisinin in vitro. Antimicrob. Agents Chemother. 53:1362-1366.
23. Nelson, A. L., A. Purfield, P. McDaniel, N. Uthaimongkol, N. Buathong, S. Sriwichai, R. S. Miller, C. Wongsrichanalai, and S. R. Meshnick. 2005. pfmdr1 genotyping and in vivo mefloquine resistance on the Thai-Myanmar border. Am. J. Trop. Med. Hyg. 72:586-592.
24. Ochong, E. O., I. V. van den Broek, K. Keus, and A. Nzila. 2003. Association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan. Am. J. Trop. Med. Hyg. 69:184-187.
25. Parola, P., B. Pradines, F. Simon, M. P. Carlotti, P. Minodier, M. P. Ranjeva, S. Badiaga, L. Bertaux, J. Delmont, M. Morillon, R. Silai, P. Brouqui, and D. Parzy. 2007. Antimalarial drug susceptibility and point mutations associated with drug resistance in 248 Plasmodium falciparum isolates imported from Comoros to Marseille, France in 2004-2006. Am. J. Trop. Med. Hyg. 77:431-437.
26. Pradines, B., P. Hovette, T. Fusai, H. L. Atanda, E. Baret, P. Cheval, J. Mosnier, A. Callec, J. Cren, R. Amalvict, J. P. Gardair, and C. Rogier. 2006. Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo. J. Clin. Microbiol. 44:2404-2408.
27. Pradines, B., A. Tall, T. Fusai, A. Spiegel, R. Hienne, C. Rogier, J. F. Trape, J. Le Bras, and D. Parzy. 1999. In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs. Antimicrob. Agents Chemother. 43:418-420.
28. Price, R. N., C. Cassar, A. Brockman, M. Duraisingh, M. van Vugt, N. J. White, F. Nosten, and S. Krishna. 1999. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob. Agents Chemother. 43:2943-2949.
29. Price, R. N., A. C. Uhlemann, A. Brockman, R. McGready, E. Ashley, L. Phaipun, R. Patel, K. Laing, S. Looareesuwan, N. J. White, F. Nosten, and S. Krishna. 2004. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364:438-447.
30. Price, R. N., A. C. Uhlemann, M. van Vugt, A. Brockman, R. Hutagalung, S. Nair, D. Nash, P. Singhasivanon, T. J. Anderson, S. Krishna, N. J. White, and F. Nosten. 2006. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin. Infect. Dis. 42:1570-1577.
31. Reed, M. B., K. J. Saliba, S. R. Caruana, K. Kirk, and A. F. Cowman. 2000. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403:906-909.
32. Sasi, P., A. Abdirahman, L. Mwai, S. Muriithi, J. Straimer, L. Schieck, A. Rippert, M. Bashraheil, A. Salim, J. Peshu, K. Awuondo, B. Lowe, M. Pirmohamed, P. Winstanley, S. Ward, A. Nzila, and S. Borrmann. 2009. In vivo and in vitro efficacy of amodiaquine against Plasmodium falciparum in an area of continued use of 4-aminoquinolines in East Africa. J. Infect. Dis. 199:1575-1582.
33. Sidhu, A. B., A. C. Uhlemann, S. G. Valderramos, J. C. Valderramos, S. Krishna, and D. A. Fidock. 2006. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J. Infect. Dis. 194:528-535.
34. Sidhu, A. B., S. G. Valderramos, and D. A. Fidock. 2005. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol. Microbiol. 57:913-926.
35. Sidhu, A. B., D. Verdier-Pinard, and D. A. Fidock. 2002. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298:210-213.
36. Sisowath, C., P. E. Ferreira, L. Y. Bustamante, S. Dahlstrom, A. Martensson, A. Bjorkman, S. Krishna, and J. P. Gil. 2007. The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. Trop. Med. Int. Health 12:736-742.
37. Sisowath, C., I. Petersen, M. I. Veiga, A. Martensson, Z. Premji, A. Bjorkman, D. A. Fidock, and J. P. Gil. 2009. In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. J. Infect. Dis. 199: 750-757.
38. Sisowath, C., J. Stromberg, A. Martensson, M. Msellem, C. Obondo, A. Bjorkman, and J. P. Gil. 2005. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J. Infect. Dis. 191:1014-1017.
39. Thanh, N. X., T. N. Trung, N. C. Phong, N. X. Thien, B. Dai, G. D. Shanks, M. Chavchich, and M. D. Edstein. 2009. Open label randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in central Vietnam. Trop. Med. Int. Health 14:504-511.
40. Uhlemann, A. C., M. Ramharter, B. Lell, P. G. Kremsner, and S. Krishna. 2005. Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. J. Infect. Dis. 192:1830-1835.
41. Ursing, J., P. E. Kofoed, L. Rombo, and J. P. Gil. 2006. No pfmdr1 amplifications in samples from Guinea-Bissau and Liberia collected between 1981 and 2004. J. Infect. Dis. 194:716-718.
42. Yeka, A., G. Dorsey, M. R. Kamya, A. Talisuna, M. Lugemwa, J. B. Rwakimari, S. G. Staedke, P. J. Rosenthal, F. Wabwire-Mangen, and H. Bukirwa. 2008. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. PLoS One 3:e2390.